Clinical trial
Ferumoxytol in Improving MR Imaging in Patients With High-Grade Brain Tumors or…
NCT00103038 · OHSU Knight Cancer Institute, Other · Completed
Key facts
| NCT number | NCT00103038 |
|---|---|
| Title | Ferumoxytol in Improving MR Imaging in Patients With High-Grade Brain Tumors or Cerebral Metastases |
| Official title | NCI-Sponsored Multi-Disciplinary Study for MR Imaging of Intravenous Superparamagnetic Crystalline Particle Ferumoxytol in Primary High-Grade Brain Tumors and/or Cerebral Metastases |
| Lead sponsor | OHSU Knight Cancer Institute, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Study type | Interventional |
| Conditions | Central Nervous System Lymphoma, Malignant Glioma, Metastatic Malignant Neoplasm in the Brain |
| Intervention type | Drug, Procedure |
| Interventions | 3 Tesla Magnetic Resonance Imaging, Dynamic Contrast-Enhanced Magnetic Resonance Imaging, Dynamic Susceptibility Contrast-Enhanced Magnetic Resonance Imaging, Ferumoxytol, Gadolinium, MRI-Based Angiogram |
| Enrollment | 155 |
| Start date | Jun 4, 2004 |
| Primary completion | May 10, 2016 |
| Completion | Jun 10, 2016 |
| First posted | Feb 8, 2005 |
| Last update posted | Jun 9, 2022 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: